Ho F - Search Results

1

The GPR171 pathway suppresses T cell activation and limits antitumor immunity.

Fujiwara Y, Torphy RJ, Sun Y, Miller EN, Ho F, Borcherding N, Wu T, Torres RM, Zhang W, Schulick RD, Zhu Y. Fujiwara Y, et al. Among authors: ho f. Nat Commun. 2021 Oct 6;12(1):5857. doi: 10.1038/s41467-021-26135-9. Nat Commun. 2021. PMID: 34615877 Free PMC article.

2

GPR182 limits antitumor immunity via chemokine scavenging in mouse melanoma models.

Torphy RJ, Sun Y, Lin R, Caffrey-Carr A, Fujiwara Y, Ho F, Miller EN, McCarter MD, Lyons TR, Schulick RD, Kedl RM, Zhu Y. Torphy RJ, et al. Among authors: ho f. Nat Commun. 2022 Jan 10;13(1):97. doi: 10.1038/s41467-021-27658-x. Nat Commun. 2022. PMID: 35013216 Free PMC article.

3

ASO Author Reflections: Revisiting the Role of Induction Chemotherapy Plus Neoadjuvant Chemoradiation for Esophageal and Gastroesophageal Junction Adenocarcinoma.

Torphy RJ, Ho F, McCarter MD. Torphy RJ, et al. Among authors: ho f. Ann Surg Oncol. 2021 Oct;28(11):6058-6059. doi: 10.1245/s10434-021-10014-0. Epub 2021 Apr 17. Ann Surg Oncol. 2021. PMID: 33866468 No abstract available.

4

Adjuvant Therapy for Stage III Melanoma Without Immediate Completion Lymph Node Dissection.

Torphy RJ, Friedman C, Ho F, Leonard LD, Thieu D, Lewis KD, Medina TM, Robinson WA, Gonzalez RC, Stewart CL, Kounalakis N, McCarter MD, Gleisner A. Torphy RJ, et al. Among authors: ho f. Ann Surg Oncol. 2022 Feb;29(2):806-815. doi: 10.1245/s10434-021-10775-8. Epub 2021 Sep 19. Ann Surg Oncol. 2022. PMID: 34537899

5

[No title available]

[No authors listed] [No authors listed] PMID: 34564771

6

Neoadjuvant Treatment in Pancreatic Cancer.

Oba A, Ho F, Bao QR, Al-Musawi MH, Schulick RD, Del Chiaro M. Oba A, et al. Among authors: ho f. Front Oncol. 2020 Feb 28;10:245. doi: 10.3389/fonc.2020.00245. eCollection 2020. Front Oncol. 2020. PMID: 32185128 Free PMC article. Review.

7

Induction Chemotherapy Plus Neoadjuvant Chemoradiation for Esophageal and Gastroesophageal Junction Adenocarcinoma.

Ho F, Torphy RJ, Friedman C, Leong S, Kim S, Wani S, Schefter T, Scott CD, Mitchell JD, Weyant MJ, Meguid RA, Gleisner AL, Goodman KA, McCarter MD. Ho F, et al. Ann Surg Oncol. 2021 Nov;28(12):7208-7218. doi: 10.1245/s10434-021-09999-5. Epub 2021 Apr 21. Ann Surg Oncol. 2021. PMID: 33884489 Free PMC article.

8

Definitive chemoradiation for primary oral cavity carcinoma: A single institution experience.

Scher ED, Romesser PB, Chen C, Ho F, Wuu Y, Sherman EJ, Fury MG, Wong RJ, McBride S, Lee NY, Riaz N. Scher ED, et al. Among authors: ho f. Oral Oncol. 2015 Jul;51(7):709-15. doi: 10.1016/j.oraloncology.2015.04.007. Epub 2015 May 7. Oral Oncol. 2015. PMID: 25958830 Free PMC article.

9

Patients with low lying lymph nodes are at high risk for distant metastasis in oropharyngeal cancer.

Riaz N, Setton J, Tam M, Sherman E, Ho F, Katsoulakis E, Wong R, Wolden S, Rao S, Lee N. Riaz N, et al. Among authors: ho f. Oral Oncol. 2014 Sep;50(9):863-8. doi: 10.1016/j.oraloncology.2014.06.008. Epub 2014 Jul 17. Oral Oncol. 2014. PMID: 25043881

10

Irradiation for locoregionally recurrent, never-irradiated oral cavity cancers.

Lok BH, Chin C, Riaz N, Ho F, Hu M, Hong JC, Shi W, Zhang Z, Sherman E, Wong RJ, Morris LG, Ganly I, Wolden SL, Rao SS, Lee NY. Lok BH, et al. Among authors: ho f. Head Neck. 2015 Nov;37(11):1633-41. doi: 10.1002/hed.23806. Epub 2014 Aug 28. Head Neck. 2015. PMID: 24954094 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

697 results

Search Page